𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia

✍ Scribed by Buresh, A; Perentesis, J; Rimsza, L; Kurtin, S; Heaton, R; Sugrue, M; List, A


Book ID
110056092
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
132 KB
Volume
19
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy of decitabine in the treatment
✍ P.W. Wijermans; B. RΓΌter; M.R. Baer; J.L. Slack; H.I. Saba; M. LΓΌbbert πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 96 KB

Chronic myelomonocytic leukemia (CMML) characterized by cytopenias, bone marrow and peripheral blood cell dysplasia is notoriously hard to treat. Recent reclassification of CMML as a myelodysplastic/myeloproliferative (MDS/MPS) disease rather than a myelodysplastic syndrome (MDS) by the World Health

Rapidly progressive cutaneous vasculitis
✍ Adam M. Rosen; Kenneth Haines Iii; Martin S. Tallman; David Hakimian; Dr. Rosali πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 750 KB

This case report reviews the unique development of a vasculitic syndrome involving medium-sized arteries in a man with chronic myelomonocytic leukemia (CMMoL). This case has many features in common with cutaneous polyarteritis nodosa (CPAN), and this may represent the first instance in which CPAN de